The level of expression of surface antigens was studied on neutrophils from paired samples of blood and synovial fluid of patients with rheumatoid arthritis (RA). By measuring the immunofluorescence of labelled monoclonal antibodies it was shown that on joint neutrophils there was an increase in expression of complement receptor 3 (CR3) and granulocyte functional antigens 1 and 2 compared with blood neutrophils, whereas the expression of GpIIb-IIIa was reduced. The pattern of expression was the same as that seen with in vitro activation and strongly suggests that activation is occurring within the joint.
An understanding of the regulation of human neutrophil function has been enhanced by two sets of observations. Firstly, neutrophils are capable of being activated by naturally occurnrng cytokines such as colony stimulating factors1 and tumour necrosis factor.2 It has been suggested that these cytokines are responsible for the activation of neutrophils in vivo, especially at sites of inflammation such as that of RA. 3 Additionally, neutrophils are activated by complement component C5a, and a C5a related chemotactic activity has been demonstrated in synovial fluid (SF) from patients with RA.s Secondly, the functional status of neutrophils is reflected by changes in surface antigens. The (28) 11 (10) 10 (14) 25 (14) 31 (21) 58 92 12 142 (9) 266 (10) 12 (8) 12 (9) 10 (9) The expression of CR3, GFA-1, and GFA-2 on synovial fluid neutrophils was greater than on neutrophils from peripheral blood ( Table 1 ; p<0003); significantly increased antigen expression on SF neutrophils was seen in at least 10 samples for all of these antigens. In contrast, the expression of GpIIb-IIIa was reduced on SF neutrophils (p<O-00l). Plots of the relative expression of the antigens in blood versus synovial fluid illustrate these features (Fig. 1) . The binding of Hu-PI-ml was studied to assess specific binding to platelets and thus exclude the possibility that the binding of FMLP significantly enhanced the expression of CR3, GFA-1, and GFA-2 but reduced that of GpIIb-IIIa on PB neutrophils (p<002) (data shown for CR3 and GpIIb-IIIa in Fig. 2 ). The effect of FMLP on SF neutrophils was less consistent and ultimately not significant (p>0.06), though the expression of CR3, GFA-1, and GFA-2 tended to be enhanced (Fig. 3) .
Discussion
We have shown that in patients with RA neutrophils from SF have altered expression of surface molecules. Furthermore, this altered expression follows a pattern seen when neutrophils are activated in vitro, strongly suggesting that this activation is occurring in vivo.
The role of neutrophils in the pathogenesis of articular destruction in RA is unclear. These cells predominate in the SF, however, during acute exacerbations of the disease, are seen in the vicinity of synovial blood vessels or at the articular margin, and are known to secrete a number of pro-inflammatory mediators after stimulation in vitro.3 Studies comparing the functional activity of SF neutrophils with those from PB have yielded conflicting results.12-15 It has been noted that the phagocytic activity of SF neutrophils is depressed or enhanced, whereas no differences in resting enzyme content or stimulated enzyme release are apparent when differences in viability are taken into account.13 Potential explanations for these discrepancies include technical differences in isolation methods or assays and variable degrees of activation in vivo which could render the cells refractory to further stimulation in vitro. This was clarified by the use of antigen expression as an independent marker of function status.
Previous work in this laboratory has identified two antigens, GFA-1 and GFA-2, which are involved in antibody dependent killing,'0 and a third, GpIIb-IIIa, the receptor for fibrinogen and fibronectin, which is involved in cell adhesion.9 10 As has been shown for CR1 and CR3 the expression of GFA-1 and GFA-2 is enhanced by stimuli which activate neutrophilsl'; this was confirmed in the present study, and it was also shown that the expression of GpIIb-IIIa is reduced. Therefore it seemed that the relative level of expression of these antigens would serve as a marker of the functional status of neutrophils from sites of inflammation such as synovial fluid. Preliminary investigations (data not shown) have confirmed that the conditions of neutrophil isolation can affect the expression of surface antigens.16 Consequently, SF and PB neutrophils were prepared identically, and the pattern of expression of several antigens was compared, rather than relying on the absolute expression of any one antigen.
The results of the present study show that the expression of CR3, GFA-1, and GFA-2 is increased on SF neutrophils and that of GpIIb-IIIa is diminished compared with PB cells. This is in keeping with the pattern of reactivity after stimulation in vitro and supports the hypothesis that the SF neutrophils have been activated in vivo. These findings are also consistent with enhanced CR3 expression on neutrophils from sterile exudates17 and a recent demonstration of increased C3 receptors on SF neutrophils using a rosette assay.14 On the other hand, our failure to stimulate consistently further enhancement of these antigens on SF neutrophils by incubation with FMLP in vitro is not necessarily contrary to the finding of increased FMLP receptors and responsiveness after exudation'7 as the nature and duration of the in vivo stimulus could not be ascertained or controlled. The level of activation of PB neutrophils was not addressed in this study, firstly, because our prime interest was in expression on SF neutrophils and, secondly, because cross sectional analysis would have been hard to interpret with wide ranges between individuals.
Our findings have several implications for the management of inflammatory disorders. Firstly, the monitoring of neutrophil activation antigens may provide an independent assessment of the efficacy of anti-inflammatory treatment, and could ultimately be a very useful test. As baselines differ between individuals these tests will need to be performed serially or, as we have in this communication, by comparing two sites in the body. Secondly, it is possible that the pattern of antigenic changes may reflect the agent responsible for activation. We have already noted that activation mediated by tumour necrosis factor results in quantitatively and qualitatively different changes in these antigens,2 and it is thus possible that in the future therapy could be tailored according to these parameters. Thirdly, the present findings clearly establish that neutrophils have an altered phenotype consistent with a state of activation of the cell in the synovium and suggest the possibility that the localised activation of neutrophils in the joint may play a part in tissue destruction observed in patients with RA. 
